Prognostic Factors for Survival in Transverse Colon Cancers

Kucukarda A., Gokyer A., Sayin S., Gokmen I., Ozcan E., Kostek O., ...Daha Fazla

JOURNAL OF GASTROINTESTINAL CANCER, cilt.53, sa.1, ss.31-40, 2022 (ESCI) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 53 Sayı: 1
  • Basım Tarihi: 2022
  • Doi Numarası: 10.1007/s12029-021-00675-1
  • Dergi Adı: JOURNAL OF GASTROINTESTINAL CANCER
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, EMBASE, MEDLINE
  • Sayfa Sayıları: ss.31-40
  • Anahtar Kelimeler: Transverse colon cancer, Prognosis, Survival, BRAF V600E, Pathological stage, COLORECTAL-CANCER, MICROSATELLITE-INSTABILITY, ADJUVANT CHEMOTHERAPY, PROXIMAL COLON, STAGE-II, FLUOROURACIL, MUTATION
  • Marmara Üniversitesi Adresli: Evet

Özet

Background Transverse colon cancer (TCC) is a rare condition that accounts for 10% of all colon cancers. TCC was accepted more likely right-sided colon cancers. We aimed to investigate whether TCC differs from other colon tumors by using clinical, pathological, and molecular prognostic factors known to be important in colon cancer and if it differs in its own anatomical structure.